1.
Seah J-A, Sridhar S, Wood L, Blais N, North S, Rahim Y, et al. Neoadjuvant chemotherapy (NC) should be administered to fit patients with newly diagnosed, potentially resectable muscle-invasive urothelial cancer (MIUC) of the bladder – A 2013 CAGMO Consensus Statement and Call for a Streamlined Referral Process. CUAJ [Internet]. 2013 Oct. 9 [cited 2026 Apr. 23];7(9-10):312-8. Available from: https://cuaj.ca/index.php/journal/article/view/1506